Showing results (1-10 of 140) with videos related to
Sort By:
Pageof 14
Current Pharmaceutical Design|May 29, 2012
Tobacco, inflammation, and respiratory tract cancerJavier Milara, Julio CortijoCurrent Opinion in Pulmonary Medicine|December 17, 2005
Mucus and MUC in asthmaEsteban J Morcillo, Julio CortijoOncotarget|April 29, 2020
Pirfenidone anti-fibrotic effects are partially mediated by the inhibition of MUC1 bioactivationBeatriz Ballester, Javier Milara, Julio CortijoJournal of Clinical Medicine|September 14, 2019
Mucins as a New Frontier in Pulmonary FibrosisBeatriz Ballester, Javier Milara, Julio CortijoEuropean Respiratory Review : an Official Journal of the European Respiratory Society|February 4, 2021
The role of mucin 1 in respiratory diseasesBeatriz Ballester, Javier Milara, Julio CortijoInternational Journal of Molecular Sciences|February 2, 2019
Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular TargetsBeatriz Ballester, Javier Milara, Julio CortijoArchivos De Bronconeumologia|February 15, 2011
[Pharmacological profile of roflumilast]Julio Cortijo Gimeno, Esteban Morcillo SánchezPharmacology & Therapeutics|June 1, 2005
PDE4 inhibitors as new anti-inflammatory drugs: effects on cell trafficking and cell adhesion molecules expressionMaría Jesús Sanz, Julio Cortijo, Esteban J MorcilloPhysiological Reviews|June 4, 2025
Immunomodulatory properties of transmembrane mucins: from chronic diseases to cancerPaula Montero, Inés Roger, Javier Milara, et al.International Journal of Molecular Sciences|June 2, 2021
The Role of JAK/STAT Molecular Pathway in Vascular Remodeling Associated with Pulmonary HypertensionInés Roger, Javier Milara, Paula Montero, et al.Pageof 14